HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Guidelines for the management of familial hypercholesterolemia.

Abstract
Familial hypercholesterolemia (FH) is a highly prevalent autosomal dominant hereditary disease, generally characterized by three major signs, hyper-low-density-lipoprotein (LDL) cholesterolemia, tendon/skin xanthomas and premature coronary artery disease (CAD). Because the risk of CAD is very high in these patients, they should be identified at an early stage of their lives and started on intensive treatment to control LDL-cholesterol. We here introduce a new guideline for the management of FH patients in Japan intending to achieve better control to prevent CAD. Diagnostic criteria for heterozygous FH are 2 or more of 1) LDL-cholesterol ≥180 mg/dL, 2) tendon/skin xanthoma(s), and 3) family history of FH or premature CAD within second degree relatives, for adults; and to have both 1) LDL-cholesterol ≥140 mg/dL and 2) family history of FH or premature CAD within second degree relatives, for children. For the treatment of adult heterozygous FH, intensive lipid control with statins and other drugs is necessary. Other risks of CAD, such as smoking, diabetes mellitus, hypertension etc., should also be controlled strictly. Atherosclerosis in coronary, carotid, or peripheral arteries, the aorta and aortic valve should be screened periodically. FH in children, pregnant women, and women who wish to bear a child should be referred to specialists. For homozygotes and severe heterozygotes resistant to drug therapies, LDL apheresis should be performed. The treatment cost of homozygous FH is authorized to be covered under the program of Research on Measures against Intractable Diseases by the Japanese Ministry of Health, Labour, and Welfare.
AuthorsMariko Harada-Shiba, Hidenori Arai, Shinichi Oikawa, Takao Ohta, Tomoo Okada, Tomonori Okamura, Atsushi Nohara, Hideaki Bujo, Koutaro Yokote, Akihiko Wakatsuki, Shun Ishibashi, Shizuya Yamashita
JournalJournal of atherosclerosis and thrombosis (J Atheroscler Thromb) Vol. 19 Issue 12 Pg. 1043-60 ( 2012) ISSN: 1880-3873 [Electronic] Japan
PMID23095242 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cholesterol, LDL
  • Lipids
  • Cholesterol
Topics
  • Achilles Tendon (metabolism)
  • Adolescent
  • Adult
  • Age Factors
  • Aged
  • Atherosclerosis (genetics, metabolism)
  • Child
  • Cholesterol (metabolism)
  • Cholesterol, LDL (metabolism)
  • Coronary Artery Disease (complications)
  • Family Health
  • Female
  • Guidelines as Topic
  • Heterozygote
  • Humans
  • Hyperlipoproteinemia Type II (diagnosis, genetics, therapy)
  • Japan
  • Lipids (chemistry)
  • Male
  • Middle Aged
  • Mutation
  • Myocardial Infarction (complications)
  • Risk
  • Xanthomatosis (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: